CLARET ASSET MANAGEMENT Corp reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 609 shares of the medical equipment provider’s stock after selling 234 shares during the period. CLARET ASSET MANAGEMENT Corp’s holdings in Intuitive Surgical were worth $329,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Nuveen Asset Management LLC grew its stake in shares of Intuitive Surgical by 32,872.7% in the 2nd quarter. Nuveen Asset Management LLC now owns 1,847,791 shares of the medical equipment provider’s stock valued at $969,259,000 after buying an additional 1,842,187 shares during the period. Morgan Stanley grew its stake in shares of Intuitive Surgical by 39.1% in the 2nd quarter. Morgan Stanley now owns 4,288,986 shares of the medical equipment provider’s stock valued at $2,249,785,000 after buying an additional 1,204,750 shares during the period. Thoroughbred Financial Services LLC grew its stake in shares of Intuitive Surgical by 101,543.0% in the 2nd quarter. Thoroughbred Financial Services LLC now owns 864,982 shares of the medical equipment provider’s stock valued at $86,498,000 after buying an additional 864,131 shares during the period. Coatue Management LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $302,483,000. Finally, FMR LLC grew its stake in shares of Intuitive Surgical by 7.3% in the 1st quarter. FMR LLC now owns 6,807,862 shares of the medical equipment provider’s stock valued at $3,884,429,000 after buying an additional 462,957 shares during the period. Hedge funds and other institutional investors own 85.87% of the company’s stock.
In related news, EVP Curet Myriam sold 4,974 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $532.14, for a total value of $2,646,864.36. Following the transaction, the executive vice president now owns 3,851 shares of the company’s stock, valued at approximately $2,049,271.14. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Salvatore Brogna sold 1,171 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $505.23, for a total transaction of $591,624.33. Following the completion of the transaction, the chief operating officer now directly owns 5,933 shares in the company, valued at approximately $2,997,529.59. The disclosure for this sale can be found here. In the last ninety days, insiders sold 25,869 shares of company stock worth $13,664,252. 1.70% of the stock is owned by insiders.
Several brokerages have recently commented on ISRG. Canaccord Genuity restated a “buy” rating and issued a $610.00 target price (up from $575.00) on shares of Intuitive Surgical in a research note on Friday, July 19th. UBS Group set a $560.00 target price on Intuitive Surgical and gave the company a “hold” rating in a research note on Friday, July 19th. ValuEngine downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, July 12th. BidaskClub downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, September 11th. Finally, Piper Jaffray Companies raised their target price on Intuitive Surgical from $610.00 to $633.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating to the company. Intuitive Surgical presently has a consensus rating of “Hold” and an average price target of $575.33.
Shares of NASDAQ ISRG opened at $518.03 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $430.24 and a fifty-two week high of $589.32. The stock has a market cap of $59.70 billion, a price-to-earnings ratio of 54.59, a PEG ratio of 3.74 and a beta of 1.13. The firm’s 50-day simple moving average is $516.49 and its 200 day simple moving average is $518.54.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.23 by $1.02. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the firm earned $2.76 EPS. The firm’s revenue for the quarter was up 20.9% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 10.12 EPS for the current fiscal year.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: Liquidity
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.